June’s top stories: NIH’s Phase I/II trial for chikungunya, Boehringer & Eli Lilly’s empagliflozin trial

Image: A female Aedes aegypti mosquito, one of the two species that spreads chikungunya virus. Photo: courtesy of Centres for Disease Control and Prevention (CDC).